- Assessed current New York State Department of Corrections and Community Supervision (DOCCS) policies and practices for medical parole and identified opportunities for improvements.
- Analyzed a sample of 251 cases using detailed case-level data for medical parole requests between 2013 and 2015. Among the findings:
- Only 12% of requests for medical parole made it as far as release.
- 55% of initial medical parole requests and 44% of those approved were for incarcerated people ages 55 and older.
- The six most common conditions for medical parole were: cancer; end-stage liver disease; cerebrovascular disease or accident; diabetes or other endocrine disorders; pulmonary conditions; and renal disease.
- Twice as many medical parole applicants die in custody than are released.
- Developed and delivered training to more than 100 DOCCS health services staff and members of the parole board on the purpose and process of medical parole, as well as how to identify, prepare, and process applications for medical parole.
- Conducted an online survey of 155 community care providers—including hospice care facilities, nursing homes, and home care providers—to understand the context around the services and barriers for treating someone who has serious medical needs on medical parole.
- Surveyed facility clinicians, finding that 28% believed they were treating at least one eligible patient who had not yet been referred for medical parole. Clinicians identified time constraints and lack of administrative support as the primary barriers to referrals.
- Published “A Question of Compassion: Medical Parole in New York State,” a report with specific recommendations and findings on the use of medical parole in New York State.
- Identified specific changes that could make the medical parole process more effective.
- Non-legislative changes include:
- Initiating new requests for medical parole at earlier stages in people’s illnesses;
- Understanding and reducing the barriers to more medical parole requests through improved data collection capacity;
- Improving communication between DOCCS and the parole board; and
- Engaging families in the discharge planning process.
- Legislative changes include:
- Clarifying who should conduct the public safety/risk assessment;
- Rethinking the role that notification of victims and law enforcement plays, including both the length of the comment period and the information provided to them; and
- Prohibiting blanket exclusion policies for people with felony convictions in community health care settings.
Through this project, the Vera Institute found that clinicians often feel conflicted about their role in initiating medical parole requests and the burden of responsibility it imposes. Clinical staff reported a lack of clarity on how compassionate release fits into the department’s patient care mission; how to navigate the medical parole application process; and how critical a physician’s role is in early identification of potential applicants. As a result, many requests are made too late—24% of applicants in the Vera Institute’s sample died while in custody. In 50% of these cases, the inmate’s death occurred less than two months after the process was initiated.
The Vera Institute continues to collaborate with DOCCS and the State Parole Board to improve New York’s medical parole and compassionate release processes by sharpening its focus on aging inmates in New York State prisons. For example, it produced a detailed analysis of the Elder Parole Bill, which allows inmates over the age of 55 who have served at least 15 years in prison to be eligible for parole. The bill has gained momentum within the State legislature and, if passed, will have a significant impact on the State’s health, public health, and criminal justice systems. As a member of the New York State Bar Association’s Parole Reform Task Force, the Vera Institute has spearheaded additional data analyses on parole board release decisions by age, gender, and offense, all of which will inform the Association’s policy recommendations for prison release reform.
Co-Funding and Additional Funds Leveraged: N/A